Researchers Map Millions of Brain Cells to Decode Alzheimer's Symptoms
NIH-supported researchers mapped 6.3 million brain cell nuclei from 1,494 donors to uncover molecular processes linked to Alzheimer's and behavioral symptoms.
Alzheimer's disease is primarily associated with memory impairment, but some patients also experience restlessness, sleep disorders, depression, and behavioral changes. To better understand what occurs in the brain alongside these symptoms, researchers supported by the National Institutes of Health (NIH) have created a detailed map of cell activity in a brain region involved in memory and complex functions.
The team examined more than 6.3 million cell nuclei from brain tissue samples of 1,494 donors. The samples included brains from individuals with Alzheimer's, Parkinson's, vascular dementia, and other conditions, alongside control samples. The researchers focused, among other things, on gene activity in various cells within the prefrontal cortex, an area linked to memory and complex cognitive abilities.
The comparison allowed them to identify molecular processes shared across multiple diseases, alongside processes tied to a specific illness, Alzheimer's progression, or the onset of psychiatric and behavioral symptoms. As part of the project, AI-powered analysis tools were also developed, and the researchers made the data and methods available to the research community.
The map can help scientists choose research directions: which cells and processes to examine when developing diagnostic markers or more targeted treatments. However, the distance between identifying a change in a brain cell and a treatment that helps a patient remains significant. The study did not test a new drug or show that Alzheimer's can be diagnosed using the map; its importance at this stage lies in a deeper understanding of the disease and creating a foundation for future studies.
